Satisfying needs for

niche Specialty Care products

 
00 / pharma& news

18/02/2021

We are proud to announce that we recently signed an agreement

with F. Hoffmann-La Roche Ltd to acquire the worldwide rights of

Pegasys (Peginterferon alpha 2a) excl. China and Japan,

securing long-term access and supply for patients benefiting

from this well established therapy option.

For any inquiries please contact us at

Pegasys@pharmaand.com.

01 / pharma& is

pharma& is a privately owned company, aiming at satisfying needs for niche, original, Specialty Care products.

Our commitment to patient access for well-established original Specialty Care medicines and our worldwide presence of own subsidiaries, affiliated companies and partnerships, secure sustainable product availibilty in markets around the world.

02 / pharma& story

After having acquired multiple products in various therapeutic areas and having established a profound base to secure patient access and to supply products across the entire European Landscape we have expanded our footprint to serve patients around the world.

We are proud of our “every patient counts” commitment and our strong partnership network.

03 / pharma& team

All of us have been trained over decades in Top Tier Global Pharmaceutical Companies, coming together as a team, committed and enjoying to grow together.

 

Supported by our trusted network of highly qualified service providers and experts, we want to shape our future and to leave footprints for the benefits of our patients, their caregivers and our stakeholders.

04 / pharma& founders
 
 

Frank Rotmann

  • Grey LinkedIn Icon

" Throughout my 20+ years

in the industry, I have developed a track record in building

and developing organisations

for growth! "

Elmar Zagler

  • Grey LinkedIn Icon

" Having started my career in Finance, I know how to optimize businesses and

how to leverage

networks & alliances! "

05 / pharma& portfolio
05.1 / prescription medicines

Anafranil

Androskat

Asacol

Dridase

Emselex

Euphyllin

Nedios

Pegasys

05.2 / consumer health
05.3 / affiliated companies
 

06 / pharma& pharmacovigilance contact

IN GERMAN

Bei Nebenwirkungen wenden Sie sich bitte an

oder schreiben Sie ein Email an pv@drehm.at.  

Zusätzlich können Sie auch direkt über die Homepage des Bundesamtes für Sicherheit im Gesundheitswesen (http://www.basg.gv.at) Nebenwirkungsfälle melden.

IN ENGLISH

In case of adverse events, please contact

or send an Email to pv@drehm.at.  

Additionally, you can also report adverse events via your local health authorities.

IN DUTCH

Voor het melden van bijwerkingen, contacteer

of u kunt een e-mail sturen naar pharmacovigilance@bfc.nl.

Daarnaast kunt u bijwerkingen ook melden bij het Lareb, www.lareb.nl.

 
 

zr pharma& GmbH

Rauhensteingasse 10/14

1010 Vienna

Austria

  • LinkedIn - White Circle

LinkedIn

pharma& Schweiz GmbH

Poststrasse 30

6300 Zug

Switzerland

© 2021 by pharma&